FDA describes 'objectionable conditions' at New York State Psychiatric Institute
Listen now
Description
The facility's institutional review board failed to report a 2021 incident and "serious and ongoing noncompliance" by a principal investigator, according to a letter released by the federal agency this week.
More Episodes
Her advocacy work aided the discovery of a rare inherited form of early-onset Alzheimer's disease and helped connect affected people with researchers.
Published 05/20/24
Follow these four tips to avoid using the information in problematic ways, including as a proxy for environmental variables.
Published 05/16/24
The feedback could lead to "novel ways" to conduct studies and reduce health disparities, a National Institutes of Health employee says.
Published 05/13/24